NCT00065273View on ClinicalTrials.gov

Atypical Neuroleptic Drugs in People With Mental Retardation/Developmental Delay

PHASE3CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

July 31, 1998

Study Completion Date

June 30, 2001

Conditions
Mental RetardationDevelopmental Delay Disorder
Interventions
DRUG

risperidone

DRUG

clozapine

DRUG

olanzapine

Trial Locations (1)

66045

University of Kansas, Lawrence

All Listed Sponsors
lead

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

NCT00065273 - Atypical Neuroleptic Drugs in People With Mental Retardation/Developmental Delay | Biotech Hunter | Biotech Hunter